Clinical trial

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

NCT07168902

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2025-10-24

PhasePHASE2

Study timeline

Study start (actual)2025-10-24Date precision: day

Registry last updated2026-07-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Interventions

BL1107 Low doseDRUG

BL1107 High doseDRUG

Timolol maleate 0.5%DRUG

Sponsors & collaborators

Bausch & Lomb Incorporatedlead sponsor

Mapped research locations

HoustonTexas, United States1 JacksonvilleFlorida, United States1 MemphisTennessee, United States1 Fort MyersFlorida, United States1 Newport BeachCalifornia, United States1 GlendaleCalifornia, United States1 PasadenaCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07168902 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.